Algorae Pharmaceuticals Limited has released a press release.
New milestone for LCTs AI development
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Preliminary Final Report and 2022 Financial Statements
- LCT Completes Strategic A$1.285M Placement
- Half Yearly Report and Accounts
- LCT Signs Service Agreement with NZeno
- Results of Rights Issue
Later from Algorae Pharmaceuticals
- Quarterly Activity Report and Appendix 4C
- Trading Halt
- Half Year Accounts and Appendix 4D
- LCT Undertakes $2.5 Million Capital Raise Initiative
- Pause in Trading
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals